home · filing · 0001493152-25-001214
8-K
filed January 7, 2025, 6:59 PM ET
ticker AWHL
CIK 0000926617
leadership
confidence high
sentiment negative
materiality 0.50
Aspira Women's Health interim CFO John Kallassy resigns; CEO becomes principal accounting officer
Aspira Women's Health Inc.
John Kallassy resigned as Interim CFO effective January 10, 2025, for personal reasons.
CEO Dr. Sandra Milligan will serve as principal accounting officer until a permanent CFO is appointed.
Board reinstated Dr. Milligan's full salary retroactive to December 16, 2024.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Filed January 7, 2025, 6:59 PM ET
The Company’s Chief Executive Officer, Dr. Sandra Milligan, will be the Company’s principal accounting officer for the present time.
Effective 2025-01-10
Filed January 7, 2025, 6:59 PM ET
accepted the resignation for personal reasons of John Kallassy, the Company’s Interim Chief Financial Officer, effective on January 10, 2025.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Sandra Milligan was appointed as principal accounting officer at Aspira Women's Health Inc..
Action appointed as principal accounting officer
Role principal accounting officer
Exact text from the filing
The Company’s Chief Executive Officer, Dr. Sandra Milligan, will be the Company’s principal accounting officer for the present time.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
John Kallassy resigned as Interim Chief Financial Officer at Aspira Women's Health Inc..
Action resigned
Role Interim Chief Financial Officer
Exact text from the filing
accepted the resignation for personal reasons of John Kallassy, the Company’s Interim Chief Financial Officer, effective on January 10, 2025.
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-25-001214
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.